MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +75

MetLife stock gains as buyback and EPS growth stand out

AI-generated analysis

📈 MetLife reported Q2 2026 EPS of USD 2.43, beating the consensus estimate by USD 0.13.

💰 Revenue grew 10.5% year over year to reach USD 13.52 billion in the second quarter.

📉 The company achieved a net margin of 4.57% and a return on equity of 23.39%.

🔄 MetLife authorized a new USD 3 billion share repurchase plan for its shareholders.

💵 The quarterly dividend remains at USD 0.5925 per share, implying an annualized payout of USD 2.37.

📊 Analysts maintain a Buy consensus with an average price target of USD 102.21.

🚀 Morgan Stanley raised its price target from USD 103.00 to USD 111.00 following the earnings.

🏦 Wells Fargo increased its target from USD 101.00 to USD 109.00 in the same update.

🎯 The New Frontier plan is ahead of schedule with projected 2025 EPS growth of 10%.

💸 Management expects nearly USD 5 billion in free cash flow for 2025.

🤝 MetLife anticipates about USD 50 million in annualized cost synergies from the PineBridge deal.

📈 The stock closed at USD 78.45, trading below the 52-week high of USD 100.93.

Bullish Signals
  • MetLife beat Q2 EPS estimates by USD 0.13, reporting USD 2.43 per share versus a consensus of USD 2.30.
  • Revenue surged 10.5% year over year to reach USD 13.52 billion in the second quarter.
  • The company achieved a robust return on equity of 23.39% and a net margin of 4.57%.
  • MetLife authorized a substantial USD 3 billion share repurchase plan to return capital to shareholders.
  • Analysts maintain a Buy consensus with an average price target of USD 102.21, indicating upside potential.
  • Morgan Stanley raised its price target from USD 103.00 to USD 111.00 following the strong results.
  • Wells Fargo increased its target from USD 101.00 to USD 109.00, reinforcing positive analyst sentiment.
  • The New Frontier plan is ahead of schedule with a projected 2025 EPS growth of 10%.
  • Management forecasts nearly USD 5 billion in free cash flow for the year 2025.
  • MetLife expects to generate about USD 50 million in annualized cost synergies from the PineBridge acquisition.
Full Analysis
MetLife Inc. reported strong second-quarter 2026 financial results, with earnings per share (EPS) of USD 2.43, beating the consensus estimate by USD 0.13. Revenue for the quarter reached USD 13.52 billion, representing a 10.5% year-over-year increase. The company also posted a net margin of 4.57% and a return on equity of 23.39%, demonstrating solid profitability metrics. Following the earnings release, MetLife's board authorized a USD 3 billion share repurchase plan while maintaining its quarterly dividend at USD 0.5925 per share. This commitment to capital returns signals confidence in the company's cash flow generation and shareholder value creation strategy amidst a challenging market environment. Analyst sentiment remains positive, with a consensus Buy rating and an average price target of USD 102.21, which is significantly above the current stock price. Major institutions like Morgan Stanley and Wells Fargo raised their price targets following the report, citing strong operational performance and growth prospects. At the KBW Insurance Conference, MetLife highlighted that its New Frontier plan is ahead of schedule, projecting 2025 EPS growth of 10% and free cash flow of nearly USD 5 billion. Management also reaffirmed a full-year variable investment income target of USD 1.6 billion and expected cost synergies from the PineBridge acquisition. MetLife stock traded at USD 78.45 on September 8, 2026, trading below its 52-week high but well above its low. The market capitalization stood at USD 61.41 billion, reflecting investor confidence in the company's strategic initiatives and financial resilience.